We have identified a new member of the elav gene family in Xenopus laevis. This gene, Xel-1, like the other elav-related genes, encodes a putative RNA-binding protein that contains three RNA Recognition Motifs and is solely expressed in the nervous system. Xel-1 is most likely the Xenopus homologue of Hel-Nl, one of the three known human genes related to elav. Xel-1 is not expressed in early neural precursors but rather in differentiating neurons of the central nervous system, as well as in the cranial and the spinal ganglion cells. Xel-I thus appears to be an early differentiation marker for both the central and the peripheral nervous system of Xenopus laevis.
Introduction
The function and organization of the adult nervous system requires a developmental cascade of molecular events leading to the determination of neural precursors and to their differentiation into neurons. A group of factors thought to act post-transcriptionally on the establishment and maintenance of the differentiated state of neurons was first discovered in Drosophila melanogaster and more recently in humans, namely the members of the elav (embryonic lethal abnormal visual system) gene family. Genetic studies in Drosophila demonstrate that elav is required for both the development and the maintenance of neurons (Campos et al., 1985; Homyk et al., 1985; Jimenez and Campos-Ortega, 1987) . A second member of this family, rbp9, was recently cloned in D. melanogaster (Kim and Baker, 1993) . Two human elav homologues, HUD and HuC (Szabo et al., 1991) , were first characterized as autoantigens in a paraneoplastic encephalomyelitis sensory neuropathy associated with a small cell lung cancer (Graus et al., * Corresponding author, Tel.: +33 1 69417287; Fax: +33 1 69853538. 1985 Fax: +33 1 69853538. , 1986 Dalmau et al., 1990 ). The causal relationship of this pathological association remains under investigation. A third ELAV-related protein, Hel-Nl, has been recently characterized in humans (King et al., 1994) . Members of the elav family have also been found in the chicken as neuron-specific proteins recognized by an anti-Hu antibody (Marusich and Weston, 1992; Marusich et al., 1994) . In the rat, a partial cDNA elavrelated clone has been isolated by RT PCR (King et al., 1994) .
ELAV-related proteins all display three copies of the RNA Recognition Motif (RRM, Query et al., 1989) , an 80-90 amino acid domain characteristic of RNA binding proteins . Therefore, it is hypothesized that ELAV-related proteins are involved in RNA metabolism in neural cells. All RRMs contain two highly conserved sequences: a hexapeptide, RNPl and a pentapeptide, RNP2 (Bandziulis et al., 1989 , Query et al., 1989 . A single RRM plus 20-30 flanking amino acids are sufficient for sequence-specific binding to RNA (Scherly et al., 1989; Mattaj, 1989; Kenan et al., 1991; Keene and Query, 1991) . The presence of three RRMs in ELAV-related proteins may therefore allow the binding of several RNA motifs. The temporal and spatial expression patterns of the two Drosophila elav-related genes, elav and rbp9, are significantly different. Whereas elav is expressed in both the central nervous system (CNS) and in the peripheral nervous system (PNS) at all developmental stages 1991; Campos et al., 1987) , rbp9 is solely expressed in the CNS and only from the late third instar larval stage onward (Kim and Baker, 1993) . The fact that a rbp9 transgene expressed under the control of the elav promoter does not rescue elav amorphic alleles further suggests that different members of the elav family have specific functions (Yao et al., 1993) . The developmentally-regulated alternative splicing of elav-related gene transcripts increases the complexity of their expression patterns (Yao et al., 1993) . It is likely that the different developmentally regulated products are endowed with specific functions either in the choice of the target RNA or in its fate.
The only available data concerning the developmental expression pattern of the elav related genes in vertebrates comes from the study of Marusich et al. (1994) . The authors used the Mab 16All anti-Hu antibody, that recognizes all HUD, HuC and He1 Nl antigens (Liu et al., 1995) , for the detection of ELAV-related proteins at the brachial axial level of chick embryos. Hu+ cells were detected in the ventro-lateral area of the neural tube. In addition, Hu+ crest-derived cells were found in the central region of nascent dorsal root ganglia and in primary sympathetic ganglia. Migrating neural crest cells were not found to express Hu antigens.
Recent molecular data obtained in vertebrates shed new light on the function of ELAV-related proteins. The Hel-Nl and HUD proteins share the property of binding in vitro to the 3 ' untranslated region (3 'UTR) of short half-life mRNAs that contain an AU rich element (ARE) involved in the control of mRNA stability (Malter, 1989; Shaw and Kamen, 1986; Bernstein et al., 1992) . Among this class of mRNAs, the nuclear protooncogenes c-myc and c-fos, the Granulocyte Macrophage Colony Stimulating Factor (Levine et al., 1993) and the mammalian helix-loop-helix transcriptional repressor Id (King et al., 1994) , were all shown to interact with Hel-Nl. Furthermore, binding of the c-fos messenger by the HUD protein was shown to be dependent on the ARE (Liu et al., 1995) . Since these possible targets of ELAV-related proteins are involved in the control of the cell cycle and in neuronal differentiation, it can be hypothesized that ELAV-related proteins, by modulating the stability of several mRNAs, may function in the control of the proliferation, growth and differentiation of neurons.
The amphibian model should provide useful experimental possibilities for investigating the function of elav-related genes during development of the nervous system in vertebrates. To gain insights into the role of elav family genes, we searched for members of this family in Xenopus laevis. In the present study, we characterize a cDNA of Xel-I (Xenopus elav like-l), which encodes a putative protein that is strikingly similar to the human Hel-Nl protein. We describe its temporal and spatial expression throughout early development as studied by in situ hybridization.
Results

Isolation of an elav-related cDNA in Xenopus laevis
Since the Drosophila ELAV and the human HUD proteins are highly similar in the regions encoding the RRMs, we hypothesized that these regions were also conserved in putative ELAV homologous proteins in Xenopus. Thus we designed degenerate oligonucleotide primers with the aim to amplify elav-related gene sequences from Xenopus laevis. These primers are complementary to conserved sequences within RRM2 and RRM3 found in elav-related genes, though outside of the RNPl and RNP2 elements. This allowed us to avoid the amplification of sequences of the numerous RRMcontaining genes that are not related to elav. PolyA+ RNA from Xenopus brain, a tissue that is potentially enriched in elav-related mRNAs, was chosen as a starting material for RT PCR (Kawasaki, 1990) . Several sets of primers were tested; only primers 08 and 62 (see Experimental procedures) allowed us to amplify a product of the expected size (500 bp) which gave a hybridization signal with the HUD probe pHBl.5 (Szabo et al., 1991; data not shown) . Cloning and sequencing of this amplification product (clone pXP5, Fig. 1 ) confirmed that its sequence is indeed very similar to that of the known Drosophila and human elav homologues. In order to isolate a full-length cDNA clone, a Xenopus brain cDNA library was screened with the pXP5 probe. Among lo6 plaques screened, 26 positive signals were recovered. The phage giving consistently the highest hybridization signal &X17) was isolated and further analyzed.
The clone LX1 7 contains a 1 721-bp insertion that includes an open reading frame encoding a putative 389-amino acid protein. This cDNA was named Xenopus elav like-l (Xel-Z, Fig. 1 ). In the region immediately upstream of the first ATG codon, two stop codons are found in the same reading frame. Therefore, it is likely that the first ATG corresponds to the actual translation Five pg of polyA+ RNA isolated from blastula (stage 7), gastrula (stage 11). neurula (stage 18) and tailbud (stage 30) were analyzed as described in (A). The probe was a mixture of pX6 and pXll clones. A 4.5-kb Xel-I transcript was detected only in tailbud embryos. The EFl-a probe was used in order to control RNA loading (Krieg et al., 1989) .
start of the protein encoded by Xel-I. In adult brain polyA+ RNA, a major transcript of approximately 4.5 kb was detected ( Fig. 2A ) when using a pXP5 probe. It is not possible to say whether the signal corresponds to a single RNA species since alternatively spliced transcripts of similar sizes would not be distinguishable with this approach. The size difference between the transcript and the MZ7 clone indicates that this cDNA is probably a partial cDNA lacking untranslated mRNA sequences. In fact, no polyadenylation consensus sequence is present in the 3 ' region of the MI7 cDNA. This suggests that the stretch of 13 A residues found at the 3 ' end of this clone does not correspond to the polyA tail of the cDNA but rather to an internal A-rich segment of the 3' untranslated region of the mRNA.
Comparison of the putative XEL-1 protein sequence with that of the other ELAV-related proteins, Hel-Nl, HuC and HUD in humans and ELAV and RBP9 in Drasophilu, revealed a high degree of similarity (Fig. 3) . Among vertebrate sequences, the highest score (94% identity) was found for Hel-Nl, whereas 84% and 80% identities were found for HUD and HuC, respectively. Therefore, Xel-Z is likely the Xenopus homologue of the human Hel-Nl gene.
Expression of Xel-I during development
Northern blot analysis was performed on embryonic RNA using a Xel-Z probe (MZ7) (Fig. 2B) . A transcript of the same size as that observed in the brain was found in tailbud embryos (Fig. 2B) . No transcripts were detected at blastula, gastrula or neurula stages. RT PCR amplification (primers 08 and 62) was carried on polyA+ RNA of tailbud embryos (data not shown). This allowed us to test whether the transcripts revealed by Northern blot analysis in tailbud embryos were indeed those of Xel-Z and not those of other eluv-related genes possibly cross-hybridizing with the Xel-Z probe. The amplification product was cloned (PXPSE) and sequenced, revealing perfect identity between pXP5E and pXP5 originating from the adult brain. Therefore, it is likely that the RNA detected in the tailbud stage is indeed that of Xel-Z rather than that of a related transcript.
In situ hybridization was performed on embryos from the neurula stage, in which no transcripts were detected by Northern analysis, to the early tadpole stage (Fig. 4) . The pXP5 cDNA corresponding to the most divergent region of elav-related genes (71-90% identity between human ELAV-related proteins) was used as a template for the probe, thereby allowing specific detection of Xel-Z transcripts. Whole mount in situ hybridization does not reveal any expression at the neurula stage (stage 20, Fig. 4A ). Xel-Z transcripts are first detected in the early tailbud embryos (stage 22) as two bilaterally symmetrical stripes along the midline of the embryo. These Fig. 3 . Comparison of known ELAV-related proteins. The six sequences were aligned using XEL-1 as a reference. Identical residues are indicated by a dash and deletions are marked by an asterisk. The three RRMs are underlined. Sequence sources: Hel-Nl (King et al., 1994) , HUD (Szabo et al., 1991) HuC (Liu et al., 1995) , RBP9 (Kim and Baker, 1993) , ELAV (Campos et al., 1985 
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AIHPNAGRYSSVIS-Y--LTS-344 ELAV TSKIIQPQLPAFLNPQLVRRICGAMHTPVNKGLA******************------G-374 XEL-lGMTSLAGINF**********PGHAGTGW~GPF~ 338 HELNl _,__-___-I*********f- stripes run the entire length of the spinalcord and fade when reaching the cephalic region (Fig. 4B) . At stage 30 (Fig. 4C) , expression in the spinal cord increases and is also found in the brain vesicles. In the cephalic region, cranial ganglion cells are stained (see below for a detailed description of the Xel-I pattern in the cephalic region). The expression in these neural structures is maintained in stage 35 embryos (Fig. 4D ). In addition, expression of Xel-2 was detected in the retina after cross section of whole mount embryos (see below). The developmental expression pattern of Xel-I was found to be the most dynamic in the cephalic region, in particular at the level of the prospective cranial ganglia. A diagram describing the topology of the cranial ganglia in the stage 35 embryo is shown in Fig. 5E . At stage 23 (Fig. 5A) , Xel-1 transcripts are detected in cells that, according to their location, represent a subset of prospective cranial ganglion V cells (trigeminal or semilunar ganglion, Rugh, 1951; Balinsky, 1975) . Subsequently, Xel-1 expression is detected in cranial ganglion VII-VIII cells at stage 26 (acustico-facialis ganglion, Fig. 5B ), at stage 30 in cranial ganglion IX ABC cells (glossopharyngeal ganglion, Fig. 5C ) and at stage 35 in cranial ganglion X cells (vagus ganglion, Fig. 5D ). At this stage, Xel-I is expressed in all four cranial ganglia.
In the brain, before the protrusion of the eye vesicle occurs (stage 23), expression of Xel-Z is detected in the most caudal region of the brain (Fig. 5A ). This region whose rostra1 limit is marked by the cranial ganglion V corresponds to the presumptive hindbrain. The expression in the hindbrain is maintained at stage 26 (Fig. 5B) . As development proceeds, the level of transcripts in the spinal cord and the hindbrain increases. Xel-I expression is also detected in the midbrain and the forebrain (stage 30, Fig. 5C ). The expression pattern of X&-Z appears discontinuous within the dorsal cephalic region. A gap of Xel-Z expression can be observed at the dorsal junction between the forebrain and the midbrain and between that of the midbrain and the hindbrain. We compared the expression of Xel-1 in stage 30 embryos with that of the neural cell adhesion molecule (NCAM), chosen as an early marker of neural tissue (Kintner and Melton, 1987) . According to Ruiz i Altaba and Jesse1 (1991), NCAM expression defines a marked boundary between the posterior end of the midbrain and the rostra1 hindbrain. Fig. 5F shows that in stage 30 NCAM also defines a boundary between the posterior end of the forebrain and the rostra1 midbrain. The whole mount hybridization patterns observed for Xel-1 and NCAM in the brain are indeed very similar suggesting that Xel-Z expression pattern in the cephalic region follows the topology of the brain vesicles. At this stage (stage 30), in contrast to Xel-I, NCAM is expressed at a high level in the eye and not in the cranial ganglion cells. At stage 35, the latest stage that was assayed using whole mount hybridization, Xel-Z expression persists in all the brain vesicles (Fig. 5D ).
Expression of Xel-I within the neural tube
Cross-sections spaced along the antero-posterior axis of tailbud embryos after whole mount in situ hybridization were analyzed in order to identify precisely the sites of Xel-Z expression within the different cell layers of the neural tube. Cross-sections in embryos at the neurula stage (data not shown) confirmed the absence of Xel-1 expression in the neural tube as observed with whole mount in situ hybridization (Fig. 4A) . In a frontal section, through the forebrain and the midbrain at the level ABC D The marginal zone, at the periphery, and the germinal zone, next to the lumen of the neural tube, are not stained. A weak label in the gut epithelium is due to background staining since it is also observed when using a sense probe (data not shown). (E) In situ hybridization was performed on paraplast embedded sections. The transversal section passing through the spinal cord and spinal ganglia (arrows) shows that Xel-1 is expressed in both these structures. Symbols: fb, forebrain; g, gut; hb, hindbrain; I, lens; mb, midbrain; nc, notocord; Op, optic vesicle; Ot, otic vesicle, r, retina; sc, spinal cord; wm, white matter. Scale bars = 50 pm.
of the optic vesicle of a stage 26 embryo, a low level of expression is observed in the midbrain vesicle that could not be detected easily in whole mount (Fig. 6A) . This expression is restricted to a few cells in the lateral region of the midbrain. In a more caudal section passing through the hindbrain (Fig. 6B) , expression of Xel-I is detected at a higher level than in the midbrain but it is also restricted to the most lateral cells excluding the most dorsal and ventral regions of the neural tube. The highest expression level is found in the spinal cord (Fig.  6C) , excluding the germinal ventricular layer of the neural tube. Therefore, at stage 26, Xel-1 expression occurs in the most lateral cell layer all along the neural tube, except in the forebrain, generating a gradient that decreases from the caudal to the rostra1 regions of the neural tube.
At stage 30, Xel-1 is expressed in the forebrain except in its ventral region. Expression in the midbrain is enhanced when compared to that at stage 26 (Fig. 6D) . In the hindbrain, cells in the germinal zone, close to the lumen of the tube, show no expression ( Fig. 6E and F) . No expression is found in the floor plate, the most ventral region of the spinal cord (Fig. 6G) .
Later, expression in the brain vesicles and in cranial ganglia increases further (stage 35, Fig. 7A-C) and reaches the dorsal margin of the neural tube. A new site of expression appears in the presumptive retina as shown in the section through the optic vesicle (Fig. 7B) . A high level of expression is observed in cranial ganglion VII-VIII.
In contrast, no expression is detected in the otic vesicle that is closely related to this cranial ganglion (Fig. 7C) . In the spinal cord, expression of Xel-2 is localized to the mantle layer, which contains the cell bodies (Fig. 7D) . Neither the marginal layer, which contains processes originating from cells of the mantle layer, nor the luminal layer of the neuroepithelium display any detectable Xel-1 transcript.
As mentioned above, we observed a similar pattern of expression of Xel-1 and NCAM transcripts in whole mount embryos. However, the patterns differ when sections are compared (data not shown). In particular, NCAM expression domain extends all across the neural tube including the ventricular area, whereas X4-l expression domain is restricted to the lateral margin.
Expression of Xel-1 in tadpoles
In Xenopw, spinal ganglia appear from stage 40-45 onward, that is, at stages when whole mount in situ hybridization can not be performed. In order to test whether Xel-I is expressed in cells from the truncal PNS, we performed in situ hybridization on paraplast embedded sections. A transversal section of the truncal region of a stage 45 embryo shows that Xel-I transcripts are present in spinal ganglia (Fig. 7E) .
Discussion
Elav-related genes encode RNA-binding proteins that are specific to the nervous system. Two Drosophila and three human homologous genes have been characterized (Campos et al., 1985; Szabo et al., 1991; Ring et al., 1994) . Our study provides a description of the developmental expression pattern of Xel-I, the first elav-related gene characterized in amphibians. As it has been reported for other members of this gene familly, Xel-1 expression is specific of the nervous system. Our results suggest that Xel-Z is not expressed in proliferating precursors but rather in differentiating neurons.
Comparison of XEL-1 with other ELAV-related proteins
Like other ELAV-related proteins, XEL-1 contains three RRMs organized in a characteristic manner. RRMl and RRM2 are tandemly arranged and are separated from RRM3 by a 70-amino-acid long domain (Fig. 3) . The N-terminal regions of the ELAV family members are highly variable in length. As shown in the alignment displayed in Fig. 3 , the length of the XEL-1 N-terminal region is between that of the Drosophila and the human ELAV-related proteins. The sequence comparison between D. melanogaster and D. virilis also indicates that the N-terminal region of ELAV proteins is evolving faster than the region containing the three RRMs (66% and 100% identity for the two regions respectively: Yao and White, 1991) . In addition, in vivo studies showed that deletions in the N-terminal region of the D. melanogaster ORF did not modify ELAV function (Yao and White, 1991) . Therefore, the N-terminal domain of ELAV-related proteins appears to contribute in a minor way to their function.
The three RRMs are highly similar between ELAVfamily proteins in vertebrates and Drosophila. The human ELAV-related proteins share from 90.5% to 97.5% identity with XEL-1 within these three domains. It is important to note that each RRM is significantly more similar to the corresponding RRM in the protein of another species than it is to the two other RRMs in the same protein. For instance, the three RRMs of XEL-1 share only 21-37% identical amino acids. This suggests that each RRM has its own function. The region between the second and the third RRM has been termed the stringer domain (Liu et al., 1995) . This stringer domain is well conserved among vertebrates suggesting a functional constraint. However, this domain is evolving faster than the RRMs, since the stringer domain of XEL-1 and the stringer domain of HuC, HUD and Hel-Nl share 65%, 78% and 80% identity, respectively. The sequence comparison of XEL-1 and of the other ELAV family proteins demonstrates that XEL-1 is most closely related to Hel-Nl (94% identity). However, the presence of several elav-related genes in both humans and Drosophila (Liu et al., 1995; Yao et al., 1993) leads us to predict that Xel-2 may also belong to a multigenic elav gene family in Xenopus whose other members remain to be identified.
3.2. Xel-1 is expressed from the early tailbud stage onward in both the CNS and the PNS A Xel-Z transcript is detected using Northern .blot analysis in tailbud stage embryos, a result that we confirmed by whole mount in situ hybridizations with a pXP5 probe. This probe covers the stringer domain, the most divergent region outside of the N-terminal region of elav-related genes. Therefore, this probe likely recognizes specifically Xel-2 rather than other elavrelated transcripts. Xel-Z expression is only detected in structures belonging to the nervous system of the embryos. However, both the Northern analysis and whole mount in situ hybridization show that Xel-I is not expressed in neurula. This result indicates that Xel-Z is not expressed in early neural precursors. 51 (1995) 235-249 241
The first site of Xel-1 expression is found in the neural tube at the early tailbud stage (stage 22). In the CNS of tailbud embryos, the Xel-1 expression pattern differs from that of NCAM. Whereas NCAM is expressed in both the marginal and the luminal layers, Xel-1 expression is restricted to the cells located in the lateral margin of the neural tube, excluding the luminal germinal layer. According to their anatomical position, the Xel-lpositive cells are probably newly emerged post-mitotic neurons that have migrated away from the germinal ventricular neuroepithelium (Balinski, 1975) . Indeed, the timing of Xel-1 expression is consistent with that of the appearance of neurons during development in the CNS. Cells expressing neurotilament proteins were first found in stage 21-23 embryos and, as observed for Xel-I, only in the lateral margin of the developing brain (Messenger and Warner, 1989) . In addition, the expression of neurotilament proteins is first restricted to the caudal end of the brain, which is similar to what we observe for Xel-I. From stage 36 onward, Xel-I is expressed in the retina. Therefore, Xel-Z appears to be a marker for differentiating neurons in the CNS.
In the cephalic region, cells from the cranial ganglia V, VII-VIII, IX and X express Xel-Z transcripts. Therefore Xel-Z should provide a useful marker for the developmental study of cranial ganglia. As shown by the studies in Ambystoma (Stone, 1924; Yntema, 1944; Epperlein and Lofberg, 1993) and in chick embryos (Hamburger, 1961; Ayer-Le Litvre and Le Douarin, 1982) , the cranial ganglia derive from two cell populations: the cephalic neural crests and the placodes. Whether the cells expressing Xel-Z in the cranial ganglia derive from the placodes, from the neural crest or from both remains to be investigated.
At the level of the truncal region, no expression could be detected using whole mount in situ hybridization in the neural crest cells before or during their migration. However, in stage 45 tadpoles, spinal ganglia cells, which derive from the neural crest, express Xel-1 transcripts. Using anti-Hu antibodies that recognize proteins of the ELAV family in vertebrates, Marusish et al. (1994) also reported the absence of Hu positive cells among migrating neural crest cells, and the presence of Hu positive cells in neural crest derivatives such as the spinal ganglia in the chick embryo. However, this study identified a small sub-population of neurogenic cells in the PNS that express Hu antigens without being postmitotic. Due to the broad specificity of the antibody that was used (Marusish et al., 1994) , it can be hypothesized that at least some isoforms of the ELAV-related proteins are expressed in proliferating cells in the PNS of the chick.
3.3. XEL-1 function during differentiation of the nervous system XEL-1, like the other RRM proteins so far identified, probably plays a role in some aspect of RNA metabolism (Patton et al., 1993; Valcarcel et al., 1993) . However, it is not clear yet if these proteins regulate RNA processing in the nucleus or in the cytoplasm. Cellular and molecular studies on elav-related genes have brought new insights into their function. Whereas in Drosophila the ELAV and RBP9 proteins were reported to be located solely in the nuclei (Robinow and White, 1991; Kim and Baker, 1993) , several reports describe both a nuclear and a cytoplasmic localization for vertebrate ELAV-related proteins, for instance, in human adult cortex (Graus et al., 1985) and in chick embryos (Marusich and Weston, 1992; Marusich et al., 1994) . Therefore, it can be hypothesized that ELAVrelated proteins might be involved not only in nuclear processing of particular transcripts, but also in their cytoplasmic metabolism. In fact, recent studies showed that both HUD and Hel-Nl can bind specifically to the 3 '-UTR of short half-life mRNAs (Levine et al., 1993; Liu et al., 1995) . HUD and Hel-Nl might play a role in the transport of mRNA, as has already been demonstrated for other RNA binding proteins (PinolRoma and Dreyfuss, 1992, Katz et al., 1994) . Since no antibodies specific for single members of the elav family are available yet, it is not known whether particular members have specific subcellular locations. Experiments aimed at determining the subcellular localization of the XEL-1 protein are under way.
4. Experimental procedures 4.1. RNA isolation, cDNA synthesis and PCR Total RNA was isolated from Xenopus laevis brain using a Bioprobe Systems kit (ZOL 1501). Polyadenylated RNAs were prepared with the PolyATtract System III kit @omega). First-strand cDNA was synthesized according to Kawasaki (1990) . Briefly, polyA+ RNA (100 ng) resuspended in TE (Tris-Cl pH 7.5 10 mM, EDTA 1 mM) was annealed with 100 pmol of random hexanucleotides (Boehringer) by heating for 90 s at 80°C followed by 5 min cooling on ice. Reversetranscription was performed using AMV-reverse transcriptase (Boehringer) in the presence of 10 mM dNTP in a 20 ~1 reaction. For the Polymerase Chain Reaction (PCR), 2 pl of the cDNA reaction were used together with 10 ng/Ctl of each primer in the presence of Taq DNA polymerase in standard buffer from the manufacturer (Boehringer). Thirty cycles were performed, each of 30 s at 55,72 and 95°C. Several primers were selected in the most conserved region of the corresponding ELAV and HUD protein sequences Szabo et al., 1991) . Only one combination of primers, flanked by PstI or XbaI restriction sites (see Results for their exact position), gave rise to a significant PCR amplification product (primer 08: AAGATC-TAGACCCAGMAGGAICTGGA and primer 62: CGGCCTGCAGCTCCRAADGGTCCRAACAGYT-GCCA).
The major PCR product was gel-purified, digested with PstI and XbaI, fractionated on an agarose gel, purified using the Geneclean II kit (BIO 101, La Jolla, CA) and then cloned in pBluescript SK-(Stratagene). The sequence of 8 independent clones from brain cDNA was performed by the dideoxy chain termination method (Sanger et al., 1977) using the Sequenase kit (United States Biochemical). The 8 clones were all identical (pXP5). Exactly the same strategy was applied on polyA+ mRNA of embryos in order to clone an eluvrelated PCR product. In all cases, the presence of amplification products was dependent on the addition of reverse transcriptase during the synthesis of the first strand of the cDNA and of cDNA in the PCR step. This precludes the possibility of contamination of the RT-PCR products.
4.2. Library screening pXP5 was used to probe a brain cDNA library (Wechselberger et al, 1992) . From lo6 plaque forming units that were screened according to Sambrook et al. (1989) , 26 were positive. One phage, isolated with the method of Dumanski et al. (1988) , was shown to contain a 1 721-bp cDNA containing an internal EcoRI site. The two EcoRI fragments (614 and 1 107 bp) were subcloned into pBluescript SK-(Stratagene) yielding the clones pX6 and pX1 I, respectively. Both strands of these clones were sequenced.
Embryo collection
Oocytes from Xenopus laevis were obtained from females 24 h after injection of 500 units of HCG (Organon) and fertilized in vitro using a testis homogenate prepared in MBS (88 mM NaCl, 1 mM KCl, 2.4 mM NaHC03, 0.82 mM MgS04, 0.33 mM Ca(NO&, 0.41 mM CaC12 and 10 mM HEPES pH7.5). Embryos were staged according to Nieuwkoop and Faber (1967) .
RNA analysis
For the Northern blot analysis, polyA+ RNAs from staged embryos and from adult tissues were prepared as above. For each sample, 5 rg of polyA+ RNA were fractionated by electrophoresis in denaturing formaldehyde agarose gels. The RNA was transferred to Hybond-N membranes (Amersham). DNA hybridization proceeded overnight at 42°C in 50% formamide, 5x SSPE, 5 x Denhardt's solution, 0.5% SDS, 100 &ml tRNA. Filters were washed for 15 min at 65°C in 2 x SSC, 0.1% SDS and then for 30 min at 65°C in 0.1 x SSC, 0.1% SDS and exposed to X-ray film (Amersham). Filters were exposed for 24 h (Xel-2 probe) or for 2h (EFl-a cDNA probe, Krieg et al., 1989) at -80°C using intensifying screens.
Whole mount in situ hybridization
Whole mount in situ hybridization was performed with digoxigenin-labeled probes according to Harland (1991) , except that hybridization and washes were performed at 55°C and RNase treatment was omitted. The cloned PCR fragment (pXP.5) was used as a template to generate anti-sense and sense RNA probes with T7 and T3 RNA polymerase (Boehringer), respectively. The NCAM probe corresponds to a 240-bp PCR-generated fragment (a kind gift from F. Broders) that overlaps exon 17 and subcloned in pBluescript. The antisense and sense probes were synthesized using T3 and T7 RNA polymerase, respectively. All the digoxygenin-labeled probes were used at a concentration of 1 &ml and revealed using anti-digoxygenin Fab alcaline phosphatase conjugate. Detection of alcaline phosphatase activity was allowed to proceed for 2 h (NCAM) or 15 h (Xel-1) using BCIPNBT (Sigma) according to Harland (1991) . For histology, whole mount in situ hybridized embryos were dehydrated in butanol for 24 h, impregnated for 24 h in a l/l mix of butanol/Paraplast (Sherwood Medical Co., St. Louis, MO. USA) and embedded in Paraplast. Histological sections (14 pm) were dewaxed in toluene and mounted in Canada balm.
In situ hybridization on embryo sections
In situ hybridization with digoxigenin-labeled RNA probes was performed on paraplast-embedded section of paraformaldehyde-fixed embryos, using the procedure developed by Harland (Harland, 1991) and moditied by Birren (Birren et al., 1993) . Preabsorption of the anti-digoxigenin antibody with dissociated tissues was omitted.
